Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

The Mount Sinai conference on the pharmacotherapy of schizophrenia.

Marder SR, Essock SM, Miller AL, Buchanan RW, Davis JM, Kane JM, Lieberman J, Schooler NR.

Schizophr Bull. 2002;28(1):5-16. Review.

PMID:
12047022
2.

Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making.

Volavka J, Citrome L.

Expert Opin Pharmacother. 2009 Aug;10(12):1917-28. doi: 10.1517/14656560903061309. Review.

PMID:
19558339
3.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

4.

New antipsychotic agents: emerging clinical profiles.

Buckley PF.

J Clin Psychiatry. 1999;60 Suppl 1:12-7; discussion 28-30. Review.

5.

Tardive dyskinesia and new antipsychotics.

Correll CU, Schenk EM.

Curr Opin Psychiatry. 2008 Mar;21(2):151-6. doi: 10.1097/YCO.0b013e3282f53132. Review.

PMID:
18332662
6.

EPS profiles: the atypical antipsychotics are not all the same.

Weiden PJ.

J Psychiatr Pract. 2007 Jan;13(1):13-24. Review.

PMID:
17242588
7.

Pharmacotherapy of schizophrenia with comorbid substance use disorder--reviewing the evidence and clinical recommendations.

Wobrock T, Soyka M.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1375-85. doi: 10.1016/j.pnpbp.2008.02.008. Epub 2008 Feb 26. Review.

PMID:
18394768
8.

Antipsychotics in the treatment of schizophrenia: an overview.

Tandon R.

J Clin Psychiatry. 2011;72 Suppl 1:4-8. doi: 10.4088/JCP.10075su1.01. Review.

9.

Pharmacogenetics for off-patent antipsychotics: reframing the risk for tardive dyskinesia and access to essential medicines.

Ozdemir V, Aklillu E, Mee S, Bertilsson L, Albers LJ, Graham JE, Caligiuri M, Lohr JB, Reist C.

Expert Opin Pharmacother. 2006 Feb;7(2):119-33. Review.

PMID:
16433578
10.

Tardive dyskinesia: eliminated, forgotten, or overshadowed?

Remington G.

Curr Opin Psychiatry. 2007 Mar;20(2):131-7. Review.

PMID:
17278910
11.

Efficacy of newer generation antipsychotics in the treatment of schizophrenia.

Tandon R, Jibson MD.

Psychoneuroendocrinology. 2003 Jan;28 Suppl 1:9-26. Review.

PMID:
12504069
12.

Polypharmacy with second-generation antipsychotics: a review of evidence.

Pandurangi AK, Dalkilic A.

J Psychiatr Pract. 2008 Nov;14(6):345-67. doi: 10.1097/01.pra.0000341890.05383.45. Review.

PMID:
19057237
13.

Health monitoring for patients who have schizophrenia. Summary of the Mount Sinai Conference recommendations.

Covell NH, Jackson CT, Weissman EM.

Postgrad Med. 2006 Sep;Spec No:20-6. Review.

PMID:
17128658
14.

The CATIE schizophrenia trial: results, impact, controversy.

Manschreck TC, Boshes RA.

Harv Rev Psychiatry. 2007 Sep-Oct;15(5):245-58. Review.

PMID:
17924259
15.

Suicide in schizophrenia, clozapine, and adoption of evidence-based medicine.

Meltzer HY.

J Clin Psychiatry. 2005 Apr;66(4):530-3. Review. No abstract available.

PMID:
15816797
16.

[Leponex, 10 years after -- a clinical review].

Llorca PM, Pere JJ.

Encephale. 2004 Sep-Oct;30(5):474-91. Review. French.

PMID:
15627052
17.

[Psychopathology and cognitive disorders in chronic schizophrenic patients with tardive dyskinesia].

Kaiser W.

Nervenarzt. 1989 Apr;60(4):206-12. Review. German. No abstract available.

PMID:
2566936
18.

The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update.

Miller A, Hall CS, Buchanan RW, Buckley PF, Chiles JA, Conley RR, Crismon ML, Ereshefsky L, Essock SM, Finnerty M, Marder SR, Miller DD, McEvoy JP, Rush AJ, Saeed SA, Schooler NR, Shon SP, Stroup S, Tarin-Godoy B.

J Clin Psychiatry. 2004 Apr;65(4):500-8. Review.

PMID:
15119912
19.

Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis.

Hartling L, Abou-Setta AM, Dursun S, Mousavi SS, Pasichnyk D, Newton AS.

Ann Intern Med. 2012 Oct 2;157(7):498-511. Review.

PMID:
22893011
20.

Second-generation antipsychotics for schizophrenia: can we resolve the conflict?

Leucht S, Kissling W, Davis JM.

Psychol Med. 2009 Oct;39(10):1591-602. doi: 10.1017/S0033291709005455. Epub 2009 Apr 1. Review.

PMID:
19335931

Supplemental Content

Support Center